Trial Profile
A pilot, multi-center, randomized, double-blind, placebo-controlled study to evaluate nesiritide infusion, initiated post-induction of anesthesia, in the management of coronary artery bypass graft (CABG) patients requiring cardiopulmonary bypass (CPB)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Apr 2010
Price :
$35
*
At a glance
- Drugs Nesiritide (Primary)
- Indications Heart failure
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms NAPA
- Sponsors Scios
- 31 Mar 2010 Actual patient number (305) added as reported by ClinicalTrials.gov.
- 31 Mar 2010 Actual patient number (305) added as reported by ClinicalTrials.gov.
- 29 Apr 2008 New trial record.